|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.440 USD | -13.25% |
|
+19.01% | -76.47% |
| 06-30 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
054b449974a9c9d58dcfe97c27.eZDwuaMGngIQexlOWtxCoUKDTFdLXCxGaQbPyUs1tIQ.HPGggPxq01VHS3A0EqwO5hS3eggDH04cIHGbnCRCgrQ70ceAwUvHO3kcQA~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +592.88% | |||||
| +27.64% | |||||
| +17.91% | |||||
| +81.3% | |||||
| +33.1% | |||||
| +27.13% | |||||
| +24.84% | |||||
| -10.18% | |||||
| +14.72% | |||||
| -8.92% | |||||
| Average | +80.04% | |||||
| Weighted average by Cap. | +25.68% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.440USD
Average target price
9.978USD
Spread / Average Target
+592.88%
High Price Target
14.91USD
Spread / Highest target
+935.42%
Low Price Target
5.000USD
Spread / Lowest Target
+247.22%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| B. Riley |
SellBuy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.440USD
Average target price
9.978USD
Spread / Average Target
+592.88%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
